STAT+: The last ‘breakthrough’ devices to get special treatment from Medicare
Reported by STAT News · all stories from statnews.com
Editorial digest
This report examines the last medical devices designated as 'breakthrough' that will receive specific favorable treatment from Medicare. It details the end of a particular pathway for accelerated coverage.
Digests are written in our own words from the publisher's headline — we never reproduce article text. Read the original for the full reporting.
Read the full story at STAT News →More like this
Other stories our editors tagged with the same themes.
- Trusted health newsroom10/22/2026
STAT+: FDA finalizes its guidance on apps related to drugs, pharma rejoices
Federal regulators have completed formal guidelines for software applications paired with medications, drawing positive reactions from pharmaceutical manufacturers.
- Trusted health newsroom10/22/2026
STAT+: Telehealth leapfrogs FDA approval with off-label GLP-1 prescriptions for addiction
Virtual clinics are providing off-label GLP-1 therapies for substance use disorders before receiving formal regulatory authorization.
- Trusted health newsroom8/13/2026
STAT+: An investigation into Commure, and Medicare’s new-tech incentives for AI devices
An investigation examines Commure and Medicare's AI device incentives.
- Trusted health newsroom8/13/2026
STAT+: What Medicare incentives for AI-based devices mean for tech companies — and hospitals
Medicare incentives for AI-based devices affect tech companies and hospitals.
- Trusted health newsroom10/14/2026
STAT+: Lobbyists and trade groups fight to shape how states regulate medical AI
Industry representatives are working to influence state-level medical artificial intelligence rules.
- Trusted health newsroom10/15/2026
STAT+: ‘AI sandboxes’ are all the rage. Advocates scramble to control their future
Industry experts are working to influence the development of regulatory frameworks for artificial intelligence innovation zones.